Updates are available Correction dated 2022-04-22
Click to view Correction: https://doi.org/10.1038/s41572-022-00360-y
-
Authors
Moore, Ernest E. https://orcid.org/0000-0002-0419-4848
Moore, Hunter B.
Kornblith, Lucy Z. https://orcid.org/0000-0002-1861-9691
Neal, Matthew D.
Hoffman, Maureane
Mutch, Nicola J.
Schöchl, Herbert
Hunt, Beverley J. https://orcid.org/0000-0002-4709-0774
Sauaia, Angela https://orcid.org/0000-0002-8493-389X
- License Information
-
More Information
Article History
Accepted: 19 March 2021
First Online: 29 April 2021
Change Date: 22 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41572-022-00360-y
Competing interests
: E.E.M. currently receives research support from Haemonetics, Instrumentation Laboratory, Stago, Hemosonics, Diapharma, Prytime, Humacyte and Genentech; he is a co-founder of ThromboTherapeutics; he is listed as inventor on the following patents relating to blood coagulation or fibrinolysis (including assays): WO-2016073668-A1 (assignee: The Regents Of The University Of Colorado; status: published); US-9354243-B2 (assignee: Haemonetics Corporation, The Regents Of The University Of Colorado, A Body Corporate; status: granted); WO-2019014595-A1 (assignee: Thrombo Therapeutics, Inc.; status: published); EP-3215634-A1 (assignee: The Regents of the University of Colorado; status: published); EP-3303943-A1 (assignee: The Regents of The University of Colorado, A Body Corporate; status: published); WO-2021158799-A1 (assignee: The Regents Of The University Of Colorado, A Body Corporate; status: published); US-2020208194-A1 (assignee: Massachusetts Institute Of Technology, University Of Colorado; status: published). H.B.M. receives research support from Haemonetics and Instrumentation Laboratory; he is a co-founder of ThromboTherapeutics; he is listed as inventor on the following patents relating to blood coagulation or fibrinolysis (including assays): WO-2016073668-A1 (assignee: The Regents Of The University Of Colorado; status: published); WO-2019014595-A1 (assignee: Thrombo Therapeutics, Inc.; status: published); EP-3215634-A1 (assignee: The Regents of the University of Colorado; status: published); US-2020208194-A1 (assignee: Massachusetts Institute Of Technology, University Of Colorado; status: published). M.D.N. receives research support from Haemonetics, Janssen Pharmaceuticals, Accriva Diagnostics and Instrumentation Laboratory; he serves on the Scientific Advisory Board with equity stake in Haima Therapeutics. All other authors declare no competing interests.
